Cerebrovascular Diseases

FDA approval is based on results of the phase III THALES trial, in which DAPT with ticagrelor and aspirin for 30 days reduced the rate of stroke and death by 17% vs aspirin alone.

"Beyond hypertension, higher BPV is a major clinical predictor of cognitive impairment and dementia," conclude authors of a new study.

Home blood pressure monitoring, performed accurately, is the key to data that will guide optimal hypertension treatment. Dr Naomi Fisher talks with Patient Care.